12:00 AM
 | 
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Micellar paclitaxel: Phase I/II

St. Michael's Hospital researchers presented additional data from ANP's previously reported 29-patient Phase I/II study, showing improvement or stabilization of disease in 80 percent and 85 percent...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >